Buscopan IBS Relief
Last Updated on eMC 30-Oct-2015 View document | SANOFI Contact details
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 30-Oct-2015 and displayed until Current
Reasons for adding or updating:
- Improved presentation of PIL
- Change to section 6 - date of revision
Updated on 11-Sep-2013 and displayed until 30-Oct-2015
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
- Change to section 6 - date of revision
Updated on 01-Feb-2013 and displayed until 11-Sep-2013
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26-Mar-2012 and displayed until 01-Feb-2013
Reasons for adding or updating:
- Change to date of revision
- Change to warnings or special precautions for use
- Change to side-effects
- Change to drug interactions
- Change to dosage and administration
Updated on 08-May-2009 and displayed until 26-Mar-2012
Reasons for adding or updating:
- Change to packaging
- Change to date of revision
- Change to name of manufacturer
Updated on 12-Sep-2008 and displayed until 08-May-2009
Reasons for adding or updating:
- Change due to user-testing of patient information
- Change of inactive ingredient
- Change to date of revision
Updated on 15-Mar-2007 and displayed until 12-Sep-2008
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
SANOFI
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
+44 (0)1483 535 432
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue